Feedback / Questions
RPESC-RPE-4W - Luxa Biotechnology
https://www.businesswire.com/news/home/20250429713414/en/Luxa-to-Present-Phase-12a-Clinical-and-Preclinical-Data-on-RPESC-RPE-4W-Therapy-for-Dry-AMD-at-2025-ARVO-Annual-Meeting
Apr 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next